Compass Therapeutics, Inc. Stock
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
23:00:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.8567 USD | -4.93% |
|
-24.19% | -84.05% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
| Market Cap | 154M 137M 128M 117M 220M 14.83B 222M 1.55B 600M 7.58B 579M 567M 24.33B | P/E 2026 * |
-1.73x | P/E 2027 * | -1.53x |
|---|---|---|---|---|---|
| Enterprise Value | 4.28M 3.8M 3.55M 3.24M 6.1M 412M 6.16M 42.97M 16.65M 210M 16.07M 15.73M 675M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.27x |
| Free-Float |
87.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | -4.93% | ||
| 1 week | -24.19% | ||
| Current month | -17.62% | ||
| 1 month | -63.85% | ||
| 3 months | -62.26% | ||
| 6 months | -84.28% | ||
| Current year | -84.05% |
| 1 week | 0.83 |  | 1.15 |
| 1 month | 0.83 | | 2.32 |
| Current year | 0.83 | | 6.88 |
| 1 year | 0.83 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/24/26 A | Buy | Controller/Auditor | 2,500 | 0.0014% | ||
| 4/29/26 A | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 4/29/26 A | Buy | General Counsel | 25,000 | 0.0139% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.93% | -24.19% | -76.85% | -55.15% | 154M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.70% | -3.20% | +39.69% | +110.17% | 39.07B | |
| Weighted average by Cap. | +0.12% | -1.15% | +56.90% | +138.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.51M 5.79M 5.4M 4.92M 9.28M 626M 9.37M 65.35M 25.32M 320M 24.45M 23.92M 1.03B |
| Net income | -93.27M -82.87M -77.34M -70.49M -133M -8.97B -134M -936M -363M -4.58B -350M -343M -14.71B | -112M -99.26M -92.64M -84.44M -159M -10.74B -161M -1.12B -434M -5.49B -419M -410M -17.62B |
| Net Debt | -150M -133M -124M -113M -214M -14.42B -216M -1.51B -583M -7.37B -563M -551M -23.66B | -133M -118M -110M -101M -190M -12.79B -191M -1.33B -517M -6.54B -499M -489M -20.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | $0.8567 | -4.93% | 20,754,217 |
| 01/10/26 | $0.9011 | -13.36% | 10,067,696 |
| 30/09/26 | $1.040 | -5.45% | 5,656,969 |
| 29/09/26 | $1.100 | -0.90% | 3,500,547 |
| 28/09/26 | $1.110 | -1.77% | 3,704,884 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
